close

Login

Library
Shopping Cart
Remember Me
Forgot password/Login issues?
loading animation for AJAX calls
 
 
Direct (781) 489-7301,  Toll Free (866) 285-7215

Search

Search
BCC Advance Search

Antibody Drug Conjugates: Technologies and Global Markets

  • Published: February 2014
  • |
  • Report Code: PHM161A

REPORT HIGHLIGHTS

The global market for ADC drugs reached $179 million in 2012 and $396 million in 2013. The market should reach $2.8 billion in 2018 with a compound annual growth rate (CAGR) of 48.1%.

This report provides:

  • An overview of the global market for ADCs as a part of the pharmaceutical industry that is looking for innovative technologies.
  • Analyses of global market trends, with data from 2012, 2013, and projections of compound annual growth rates (CAGRs) through 2018.
  • Examination of key market drivers and challenges.
  • Insight into regulatory hurdles and how to meet them, as well as discussion of the drugs (and the companies behind them) that have received approval.

 

SAMPLE FIGURE
GLOBAL FORECAST FOR ADC DRUGS* 2011-2018
($ MILLIONS)
GLOBAL FORECAST FOR ADC DRUGS* 2011-2018
To Contact us, click here  help


Source: BCC Research

Download Report Overview

REPORT SCOPE

SCOPE OF REPORT

This report is an analytical business tool whose primary purpose is to describe the ADC drug industry.

For the purposes of this report, commercialized ADCs are those drugs that are approved by the U.S. Food and Drug Administration (FDA) as new drugs that are not sold only as monoclonal antibodies (mAbs). The study’s main focus is on legal, prescription-required therapeutic medicines sold in the open market. For this report, the form of an ADC involving an antibody and small-molecule cytotoxin will be viewed as the ADC of today, though acknowledgement is made in this report that ADCs will expand to encompass other forms of small-molecule drugs possibly in nanoparticle size or some other type.

The study also does not cover the following: mAbs that do not contain a linker and cytotoxic agent and, thus, do not constitute an ADC; however, novel ADC technology and novel ADC-related technology will be discussed.

Again, the format of the study is organized around the following topics:

  • Major types and applications of ADC drugs.
  • Industry structure.
  • Market size and segmentation, including breakdown of sales by therapeutic area and geographic area.
  • Market drivers.
  • Market projections through 2018.
  • Competition.
  • Observations and conclusions regarding the future of the industry.

Download Report Overview

REPORT TOC

download table of contents
Pricing on the website is provided for single users and 2-5 users licenses only. All reports will be provided in a PDF format for download. To purchase multi-user licenses, please contact us at (+1)781-489-7301 or send an email to information@bccresearch.com
  Title/Chapter Name Pages Price
Antibody Drug Conjugates: Technologies and Global Markets 132 $6650
Chapter- 1: INTRODUCTION - Complimentary 4 $0
  Show Details
Chapter- 2: SUMMARY 5 $250
  Show Details
Chapter- 3: OVERVIEW OF ADCS WITHIN ANTIBODY DRUG CLASS 37 $3296
  Show Details
Chapter- 4: MARKET FORECAST FOR ADCS 28 $2616
  Show Details
Chapter- 5: COMPANY PROFILES 58 $3383
  Show Details
 
  List of Tables
  List of Figures
Recommended combos for Forecast Model
+

BCC Research Report

Price: $6650

=

Total Price: $11650

Combo Price: $8000

Discount will be applied automatically after you will add the forecast model and any report to your cart.

 
Select License type:
buy now
download report overview
Want to find out more
about this report?
request more info
Get Notified
on all the latest research reports
Subscribe

Choose your License

loading animation for AJAX calls